Aurobindo Pharma’s arm gets 3 observations from USFDA for Telangana API facility

15 Dec 2025 Evaluate

The United States Food and Drug Administration (USFDA) has inspected Aurobindo Pharma’s wholly owned subsidiary -- Apitoria Pharma’s API manufacturing facility - Unit-V situated at Sangareddy district in Telangana. The inspection was conducted from December 1 to December 12, 2025. The USFDA has issued ‘Form 483’ with total of 3 observations which are procedural in nature.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1172.65 -25.85 (-2.16%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1736.85
Dr. Reddys Lab 1215.65
Cipla 1466.05
Zydus Lifesciences 895.00
Lupin 2189.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×